Abbott to take a pause after deal spree

Abbott last year bolstered its medical device and diagnostic businesses, scooping up rivals St. Jude Medical and Alere for a combined $30 billion.Analysts applauded the strong results, with New York-based brokerage Leerink calling Abbott "an execution story" due to the successful integration of the two companies it bought.